{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/17/3313361/0/en/Avalyn-Completes-Target-Enrollment-in-Phase-2b-MIST-Trial-of-AP01-Inhaled-Pirfenidone-for-Patients-with-Progressive-Pulmonary-Fibrosis.html", "message": "News view counter 804295 successfully enlarged"}